Search results
From Self-sufficiency
- ...ition to being an H-1 [[histamine]] [[Receptor (biochemistry)|receptor]] [[Receptor antagonist|antagonist]], chlorpheniramine has been shown to work as a [[ser [[Category:H1 receptor antagonists]]6 KB (745 words) - 15:05, 6 July 2010
- ...n augment the [[antiemetic]] effect of [[5-HT3 antagonist|5-HT<sub>3</sub> receptor antagonists]] like [[ondansetron]]. In [[brain tumour]]s (primary or metas [[pt:Dexametasona]]18 KB (2,498 words) - 16:41, 27 September 2010
- ...an activate and influence biochemical behaviour of most cells. The steroid/receptor complexes dimerise and interact with cellular DNA in the nucleus, binding t [[pt:Prednisolona]]7 KB (872 words) - 16:41, 27 September 2010
- ....<ref>Granger, P. et al. Modulation of the gamma-aminobutyric acid type A receptor by the antiepileptic drugs carbamazepine and phenytoin. Mol. Pharmacol. 47, ...128 |doi= 10.1097/00002826-200007000-00010|url=http://meta.wkhealth.com/pt/pt-core/template-journal/lwwgateway/media/landingpage.htm?issn=0362-5664&volum16 KB (2,164 words) - 16:42, 27 September 2010
- ...is specifically induced by Phenobarbital via the [[CAR]]/[[RXR]] [[nuclear receptor]] [[heterodimer]]. It is excreted primarily by the [[kidney]]s. [[pt:Fenobarbital]]20 KB (2,657 words) - 16:42, 27 September 2010
- ...to D-cycloserine's action as a partial [[agonist]] of the neuronal [[NMDA receptor]] for [[glutamate]] and have been examined in implications with sensory-rel D-cycloserine is a [[partial agonist]] at the [[glycine receptor]], and has been shown to have cognition-enhancing properties for models of5 KB (602 words) - 16:44, 27 September 2010
- ...morphine, exert their effects by binding to and activating the μ-[[opioid receptor]]. ...n|first2=MR|last3=Diphillipo|first3=MA|last4=Forst-Paulus|first4=M|issue=1 Pt 2}}</ref> (Off-label)40 KB (5,581 words) - 16:45, 27 September 2010
- ...cts. It is a [[competitive antagonist]] for the [[muscarinic acetylcholine receptor]]. It is classified as an [[anticholinergic drug]]. Being potentially dead ...of the [[vagus nerve]], blocks [[acetylcholine]] [[receptor (biochemistry)|receptor]] sites, and decreases [[bronchial]] [[secretion]]s.16 KB (2,198 words) - 16:46, 27 September 2010
- ...shizawa K, Aoki K, Takagi M, Miyatake M, Suzuki T |title=A putative sigma1 receptor antagonist NE-100 attenuates the discriminative stimulus effects of ketamin ...e the effect to ketamine being an [[N-methyl-D-aspartate receptor|NMDA]] [[receptor antagonist]].<ref>{{Cite journal|author=Zarate CA, Singh JB, Carlson PJ, ''69 KB (9,697 words) - 21:01, 24 September 2010
- ...rst4= JM |first5= D |first6= G |first7= G |first8= Investigators |issue= 6 Pt 1 |last2= Tonnelier |last3= D'athis |last4= Tréluyer |last5= Gendrel |last ...INR should be monitored closely. They may also interact with the [[GABA A receptor]] and cause neurological symptoms; this effect is augmented by certain [[no88 KB (11,930 words) - 16:46, 27 September 2010
- ...benzodiazepines acting on the benzodiazepine site on the GABA<sub>A</sub> receptor increase the opening frequency of the chloride ion channel. This explains w ...January | title = Intravenous anaesthetics inhibit nicotinic acetylcholine receptor-mediated currents and Ca2+ transients in rat intracardiac ganglion neurons.24 KB (3,339 words) - 16:46, 27 September 2010
- ...c=558205 }}</ref><ref>{{vcite journal |author=Libby G, Donnelly LA, Donnan PT, Alessi DR, Morris AD, Evans JM |year=2009 |title=New users of metformin ar ...gh AMP-activated protein kinase-dependent regulation of the orphan nuclear receptor SHP |journal=Diabetes |volume=57 |issue=2 |pages=306–14 |year=2008 |pmid=66 KB (8,976 words) - 16:47, 27 September 2010
- ...HT in rat prefrontal cortex and hypothalamus: an in vivo microdialysis and receptor binding study |journal=Neuropsychopharmacology |volume=27 |issue=6 |pages=9 ..., Casis O, Casis L |title=Effects of fluoxetine administration on mu-opoid receptor immunostaining in the rat forebrain |journal=Brain Res. |volume=817 |issue=52 KB (7,168 words) - 16:47, 27 September 2010
- ...the experiments in rats, via the action on [[arachidonic acid]] and [[NMDA receptor]]s cascade.<ref name="Gutton">{{Cite journal|author=Guitton MJ, Caston J, R [[pt:Ácido acetilsalicílico]]78 KB (10,918 words) - 16:52, 27 September 2010
- ...enegger M |title=Use-dependent inhibition of the skeletal muscle ryanodine receptor by the suramin analogue NF676 |journal=Br. J. Pharmacol. |volume=146 |issue [[pt:Suramina]]7 KB (906 words) - 16:47, 27 September 2010
- ...enolol''' ('''Tenormin''') is a selective [[beta-1 receptor|β<sub>1</sub> receptor]] [[receptor_antagonist|antagonist]], a [[drug]] belonging to the group of ...lpha-agonists (e.g. [[clonidine]]), [[ACE Inhibitor]]s or [[Angiotensin II receptor antagonist]]s such as losartan can also be given additionally. Exert cautio12 KB (1,720 words) - 16:48, 27 September 2010
- ...development, the α<sub>6</sub>β<sub>2</sub>γ<sub>2</sub> receptor increases in expression in cerebellar granule neurons, corresponding to inc [[pt:Furosemida]]12 KB (1,678 words) - 16:48, 27 September 2010
- ...D<sub>3</sub>]], [[Dopamine D4 receptor|D<sub>4</sub>]], and [[Dopamine D5 receptor|D<sub>5</sub>]]—and their variants. Dopamine is produced in several areas Via the [[dopamine receptor]]s, D<sub>1-5</sub>, dopamine reduces the influence of the indirect pathway48 KB (6,470 words) - 16:48, 27 September 2010
- '''Timolol maleate''' is a non-selective [[beta blocker|beta-adrenergic receptor blocker]]. In its oral form ('''Blocadren'''), it is used to treat [[hypert [[pt:Timolol]]4 KB (476 words) - 16:46, 19 September 2010
- ...). Spironolactone has anti-androgen activity by binding to the [[androgen receptor]] and preventing it from interacting with [[dihydrotestosterone]].<ref>{{ci ...| pmid=16840442 | pmc=1539051 }}</ref> Because it also affects [[androgen receptor]]s and other steroid receptors, it can cause [[gynecomastia]], menstrual ir12 KB (1,555 words) - 16:49, 27 September 2010
- ...or '''Zantac''') is a [[histamine]] [[H2-receptor antagonist|H<sub>2</sub>-receptor antagonist]] that inhibits [[gastric acid|stomach acid]] production. It is {{Main|H2-receptor antagonist}}5 KB (699 words) - 16:49, 27 September 2010
- ...short-acting [[beta2-adrenergic receptor agonist|β<sub>2</sub>-adrenergic receptor agonist]] used for the relief of [[bronchospasm]] in conditions such as [[a Salbutamol was the first selective Β2-receptor agonist to be marketed — in 1968. It was first sold by Allen & Hanburys u15 KB (2,005 words) - 16:49, 27 September 2010
- ...tion]] and [[mucus]] [[secretion]]. It is a non-selective [[muscarinic]] [[Receptor antagonist|antagonist]], and does not diffuse into the blood, which prevent [[pt:Ipratrópio]]5 KB (580 words) - 16:49, 27 September 2010
- ...or|5-HT<sub>3</sub> receptor]] antagonist/[[5-HT receptor|5-HT<sub>4</sub> receptor]] agonist. ...activity, D<sub>2</sub> receptor antagonist activity and 5-HT<sub>4</sub> receptor agonist activity.<ref name="Martindale34">Sweetman S, editor. Martindale: T11 KB (1,453 words) - 16:49, 27 September 2010
- ...s Type I and Type II receptor agonist), or [[RU28362]] (a specific Type II receptor agonist), to adrenalectomized animals induced changes in [[leukocyte distri .... Aldosterone and cortisol have similar affinity for the mineralocorticoid receptor however, glucocorticoids circulate at roughly 100 times the level of minera41 KB (5,644 words) - 16:50, 27 September 2010
- {{See also|Adrenergic receptor}} ...ues. Its actions vary by tissue type and tissue expression of [[adrenergic receptor]]s. For example, epinephrine causes [[smooth muscle]] relaxation in the air22 KB (2,916 words) - 16:50, 27 September 2010
- ...= 1095–101|year = 2000|pmid = 11020766|url = http://meta.wkhealth.com/pt/pt-core/template-journal/lwwgateway/media/landingpage.htm?issn=0003-3022&volum ...7862891}}</ref> Indeed, in humans given 30% N<sub>2</sub>O, benzodiazepine receptor antagonists reduced the subjective reports of feeling "high", but did not a61 KB (8,728 words) - 16:50, 27 September 2010
- ...that apparently only reacted to morphine: the mu3 [[Opioid receptor|opiate receptor]] in human tissue.<ref>{{cite journal |author=Zhu W, Cadet P, Baggerman G, ...morphine|journal=Journal of Physiology and Pharmacology|volume=55|issue=1 Pt 2|pages=279–288|date=March 2004|pmid=15082884|last2=Zhu|first2=W|last3=Ca87 KB (12,376 words) - 16:51, 27 September 2010
- ...in receptor (nociceptor) of the body, the [[TRPV1]] (older name: vanilloid receptor). Furthermore, AM404 inhibits sodium channels, as do the anesthetics lidoca <!--{{Link FA|pt}}http://pt.wikipedia.org/wiki/Wikipedia:Revalida%C3%A7%C3%A3o/Paracetamol-->54 KB (7,376 words) - 16:52, 27 September 2010
- ...''The Sympathomimetic Actions of l-Ephedrine and d-Pseudoephedrine: Direct Receptor Activation or Norepinephrine Release?''] Anesth Analg 2003; 97, pp.1239-124 ...ochemistry|steric]] orientation of the [[hydroxyl]] group is important for receptor binding and functional activity.<ref name='Ma'/>21 KB (2,906 words) - 16:51, 27 September 2010
- ...inding to the benzodiazepine site on the [[GABAA receptor|GABA<sub>A</sub> receptor]] leading to [[central nervous system]] depression.<ref name="Riss-2008"/> ...irst2 = R. | last3 = Hösl | first3 = K. | title = Subtype-selective GABAA receptor mimetics--novel antihyperalgesic agents? | url = http://www.springerlink.co78 KB (10,295 words) - 16:51, 27 September 2010
- ...d]] (GABA) [[receptor antagonist]]. Cicutoxin acts on the GABA<sub>A</sub> receptor causing a block of the [[chloride channel]] which results in [[neuronal dep [[pt:Cicuta]]29 KB (4,114 words) - 12:26, 7 July 2010
- ...nn M"/> 3) Surface enterocytes also express high levels of [[Interleukin-1 receptor]] (IL-1R) -containing inhibitory molecule. IL-1R are also referred to as si ...mponent that monitors and responds to changes in the environment. When the receptor senses a stimulus, it sends information to a '''control center''', the comp21 KB (3,070 words) - 21:41, 19 September 2010
- ...oscyamine]], and [[scopolamine]] antagonize the [[muscarinic acetylcholine receptor|muscarinic acetylcholine]] receptors in the eye. By blocking these receptor [[pt:Midríase]]9 KB (1,223 words) - 09:40, 20 September 2010
- # nonselective [[adenosine receptor]] antagonist <ref name="AR-Daly">{{cite journal | author=Daly JW, Jacobson [[pt:Pentoxifilina]]7 KB (885 words) - 09:43, 20 September 2010
- '''Tasosartan''' is an [[angiotensin II receptor antagonist]]. ...}}</ref><ref>{{cite journal |author=Dina R, Jafari M |title=Angiotensin II-receptor antagonists: an overview |journal=Am J Health Syst Pharm |volume=57 |issue=2 KB (250 words) - 09:44, 20 September 2010
- ...ncrease Thyroid Hormone Levels via Down-Regulation of the Aryl Hydrocarbon Receptor (AhR) Target Gene UDP-Glucuronosyltransferase|journal=Environmental Health [[pt:Poliestireno]]36 KB (5,017 words) - 10:14, 20 September 2010
- ...ib''' (trade name '''Votrient''') is a potent and selective multi-targeted receptor [[tyrosine kinase inhibitor]] of [[VEGFR]]-1, VEGFR-2, VEGFR-3, [[PDGFR]]-a [[pt:Pazopanib]]3 KB (324 words) - 13:12, 20 September 2010
- ...imic the molecular shape of [[adrenaline]]. It binds to [[alpha-adrenergic receptor]]s in the nasal mucosa.<ref>{{cite pmid|20030735}}</ref> Due to its [[sympa [[pt:Xilometazolina]]3 KB (395 words) - 13:14, 20 September 2010
- ...ts action on the [[D2 receptor|D2 dopamine]] and [[5HT1A|5-HT<sub>1A</sub> receptor]]s that can cause some side effects. <ref name="Tfelt">{{cite journal|autho [[pt:Ergotamina]]7 KB (986 words) - 13:14, 20 September 2010
- ...hydrochloride. It is a [[sympathomimetic]] agent with marked [[Adrenergic receptor|alpha adrenergic]] activity. It is a [[vasoconstrictor]] with a rapid acti [[pt:Nafazolina]]3 KB (391 words) - 13:14, 20 September 2010
- ...line in the management of epistaxis. Ann Otol Rhinol Laryngol, 1995. 104(9 Pt 1): p. 704-6.</ref> and eye redness due to minor irritation (marketed as [[ ...pression due to stimulation of central alpha-2 receptors and [[imidazoline receptor]]s, much like [[clonidine]].6 KB (713 words) - 13:15, 20 September 2010
- ...ction there. The cytokine factors then bind with [[endothelium|endothelial receptor]]s on vessel walls, or interact with local [[microglial cell]]s. When these ...ein]] (LBP) binds to LPS. The LBP–LPS complex then binds to the [[CD14]] receptor of a nearby [[macrophage]]. This binding results in the synthesis and relea27 KB (3,703 words) - 20:20, 20 September 2010
- ...519 |doi=10.1097/00043426-200306000-00002 |url=http://meta.wkhealth.com/pt/pt-core/template-journal/lwwgateway/media/landingpage.htm?issn=1077-4114&volum ...[[Complement Receptor 3|Macrophage-1 antigen]] ([[CD18]]) [[cell receptor|receptor]] on immune cells.<ref name=pmid15084502>{{cite pmid|15084502}} (review)</r94 KB (13,321 words) - 21:32, 20 September 2010
- ...the NMDA receptor, lead exposure decreased the amount of the gene for the receptor in part of the brain.<ref>{{cite web |url=http://www.jhsph.edu/publichealth ...434739}}</ref><ref name="pmid8035397">{{cite journal |author=Lin JL, Huang PT |title=Body lead stores and urate excretion in men with chronic renal disea90 KB (13,109 words) - 21:36, 20 September 2010
- ...driving force for the binding of drugs to their [[receptor (biochemistry)|receptor]] targets.<ref name="Eisenberg">{{cite journal |author=Eisenberg D, McLachl [[pt:Coeficiente de partição]]27 KB (3,780 words) - 20:16, 21 September 2010
- ...g to Le Châtelier's principle thereby explaining the diverse phenomena of receptor activation and desensitization.<ref name="Bio-balance">{{cite web|url=http: [[pt:Princípio de Le Châtelier]]12 KB (1,797 words) - 20:16, 21 September 2010
- ...ule, including any [[protein]], is phosphorylation. Many [[enzyme]]s and [[Receptor (proteomics)|receptors]] are switched "on" or "off" by phosphorylation. Pho ...ly into the cytoplasm. It can be recognised by the [[inositol triphosphate receptor]] (IP3R). IP3 contributes to the activation of [[protein kinase C]] (PKC).<63 KB (9,050 words) - 21:26, 21 September 2010
- ...[angiotensin II receptor antagonist]]s, which directly block [[Angiotensin receptor|angiotensin II AT<sub>1</sub> receptors]]. ...ol|DAG]] → activation of [[Inositol triphosphate receptor|IP<sub>3</sub> receptor]] in [[sarcoplasmic reticulum|SR]] → ↑intracellular Ca<sup>2+</sup>14 KB (1,818 words) - 21:27, 21 September 2010
- !Receptor <BR> (↑ = opens. ↓ = closes) <ref name=boron/> <br> <font size=1> On [[ ...[[acetylcholine]] || ↑[[Muscarinic acetylcholine receptor M2|muscarinic receptor M<sub>2</sub>]]11 KB (1,498 words) - 21:28, 21 September 2010
- !Receptor <br/> (↑ = opens. ↓ = closes) <ref name=boron/> <br> <font size=1> On [ |rowspan=2| [[nitric oxide]] || ↑[[NO receptor]] on smooth muscle || ↑[[cyclic GMP|cGMP]] --> ↑[[protein kinase g|PKG]13 KB (1,665 words) - 21:28, 21 September 2010
- ...enin-Angiotensin System: Emphasis on Blockade of the Angiotensin II Type-1 Receptor ...(ARBs) can be used to prevent angiotensin II from acting on [[angiotensin receptor]]s.11 KB (1,520 words) - 12:30, 28 January 2012
- ...tp://www.nature.com/bjp/journal/v143/n4/full/0705974a.html "Selective GABA-receptor actions of amobarbital on thalamic neurons."] ''British Journal of Pharmaco ...t (military)|frontline]].<ref>[http://www.pbs.org/wgbh/amex/bulge/filmmore/pt.html Use of sodium amytal during WWII]</ref>9 KB (1,128 words) - 22:04, 21 September 2010
- ...month= November | year= 1975 | pages= 530–4 | volume= 18 | issue= (5 Pt 1) | pmid=1102231 | accessdate= 2008-02-22}}</ref><ref name="Phillips">{{ci ...ref> and there may be other modes of action such as through [[histamine H3 receptor]]s<ref name="Girard">{{cite journal | author= Girard P, Pansart Y, Coppé M9 KB (1,159 words) - 22:06, 21 September 2010
- ...ervous]] and [[immune system]]s of animals and that activate [[cannabinoid receptor]]s , and 3. '''synthetic cannabinoids''', a structurally diverse class of m {{Main|Cannabinoid receptor}}49 KB (6,487 words) - 22:06, 21 September 2010
- ...brain: isolation, structure elucidation, and interactions with the opiate receptor |journal=Proc Natl Acad Sci USA |volume=73 |issue=7 |pages=2515–9 |year=1 ...for the κ<sub>1</sub> opioid receptors. μ opioid receptors are the main receptor through which [[morphine]] acts. Classically, μ opioid receptors are presy18 KB (2,467 words) - 22:06, 21 September 2010
- ...elieve minor throat irritation. Menthol also acts as a weak [[kappa Opioid receptor]] [[agonist]]. [[pt:Mentol]]15 KB (2,008 words) - 22:07, 21 September 2010
- ...ub>1</sub>]] and [[CB2 receptor|CB<sub>2</sub>]] [[receptor_(biochemistry)|receptor]]s, with lower [[affinity_(pharmacology)|affinity]] in comparison to [[THC] [[pt:Canabinol]]3 KB (352 words) - 22:07, 21 September 2010
- | url = http://meta.wkhealth.com/pt/pt-core/template-journal/lwwgateway/media/landingpage.htm?issn=0271-0749&volum ...affinity for [[Cannabinoid_receptor#CB1|CB<sub>1</sub>]] and [[Cannabinoid receptor#CB2|CB<sub>2</sub>]] receptors but acts as an indirect antagonist of cannab17 KB (2,198 words) - 22:07, 21 September 2010
- ...|CB<sub>1</sub>]] receptor, which is the most abundant [[G protein-coupled receptor]] in the [[brain]]. ...inoid receptor]] antagonist [[rimonabant]] (SR141716A) as well as [[opioid receptor]] antagonists (opioid blockers) [[naloxone]] and [[naloxonazine]].<ref name50 KB (6,686 words) - 22:09, 21 September 2010
- ...de Lamarck, J.B. 1785. ''Encyclopédie Méthodique de Botanique'', vol. 1, pt. 2. Paris, France, pp. 694-695</ref> Lamarck based his description of the n ...nabidiol modulates and directly activates alpha-1 and alpha-1-Beta glycine receptor function|journal = [[Pharmacology]]|volume = 83|issue = 4|pages = 217–22276 KB (10,798 words) - 22:10, 21 September 2010
- ...f the amyloid precursor protein | journal = J. Cell. Sci. | volume = 113 ( Pt 11) | issue = | pages = 1857–70 | year = 2000 | month = June | pmid = 108 ...comparisons to the signaling role of the surface [[transmembrane receptor|receptor]] protein [[Notch signaling|Notch]].<ref name="Selkoe">{{cite journal | aut36 KB (4,595 words) - 22:11, 21 September 2010
- || [[Dopamine receptor]]s at pathway terminations. ...gmental nuclei]] (''pontomesencephalotegmental complex'') || (mainly) [[M1 receptor]]s in:11 KB (1,374 words) - 22:11, 21 September 2010
- ...=|accessdate=}}</ref> Signal transduction starts with a signal to a receptor, and ends with a change in cell function. ...de the cell. The chemical signal binds to the outer portion of the receptor, changing its shape and conveying another signal inside the cell. So55 KB (7,677 words) - 22:12, 21 September 2010
- *Some [[transient receptor potential channel]]s: This group of channels, normally referred to simply a ...nion-permeable γ-aminobutyric acid-gated [[GABA receptor|GABA<sub>A</sub> receptor]].31 KB (4,177 words) - 22:12, 21 September 2010
- Loperamide is an [[opioid]]-receptor [[agonist]] and acts on the [[Mu Opioid receptor|μ-opioid receptors]] in the [[myenteric plexus]] of the large intestine; b [[pt:Loperamida]]7 KB (989 words) - 22:12, 21 September 2010
- ...antagonist|antagonist]] activity at the [[kappa opioid receptor|κ-opioid receptor]]. Buprenorphine [[hydrochloride]] was first marketed in the 1980s by Recki Suboxone contains buprenorphine as well as the [[opioid]] [[receptor antagonist|antagonist]] [[naloxone]] to deter the abuse of tablets by [[int59 KB (8,561 words) - 22:13, 21 September 2010
- ...8}}</ref> In addition, it is a synthetic strong agonist at the [[mu opioid receptor|μ-opioid]] receptors. Historically it has been used to treat [[breakthroug [[pt:Fentanil]]33 KB (4,684 words) - 21:01, 24 September 2010
- ...lly unlike [[morphine]] or [[heroin]], methadone also acts on the [[opioid receptor]]s and thus produces many of the same effects. Methadone is also used in ma ...receptor, but also has some affinity for the [[NMDA]] ionotropic glutamate receptor. It is metabolized by the enzymes [[CYP3A4]], [[CYP2B6]] and [[CYP2D6]], wi61 KB (8,865 words) - 22:13, 21 September 2010
- ...2receptorsimplications for models of schizophrenia](2002)</ref> Other NMDA receptor antagonists include [[ketamine]], [[tiletamine]], and [[dextromethorphan]]. In a similar manner, PCP and analogues also inhibit [[nicotinic acetylcholine receptor]] channels (nAChR). Some analogues have greater potency at nAChR than at NM21 KB (3,002 words) - 21:02, 24 September 2010
- ...potent [[Kappa Opioid receptor|κ-opioid]] and [[D2 receptor|D<sub>2</sub> receptor]] [[agonist]].<ref name="Zhang2005pabs" /><ref name="Seeman2009">[[#refSeem ...ain a [[Base (chemistry)|basic]] [[nitrogen]]), unlike most known [[opioid receptor]] [[ligand]]s.<ref name="Harding2006p107">[[#refHarding2006|Harding, Schmid133 KB (18,241 words) - 22:14, 21 September 2010
- As a narcotic, hydrocodone relieves [[pain]] by binding to [[opioid receptor]]s in the [[brain]] and [[spinal cord]]. It can be taken with or without f [[pt:Diidrocodeína]]30 KB (4,151 words) - 22:14, 21 September 2010
- ...ssociative]] [[hallucinogen]]. Its [[mechanism of action]] is as an [[NMDA receptor antagonist]], producing effects similar to those of the controlled substan ...7 | doi = 10.1097/ANA.0b013e31817f523f | url = http://meta.wkhealth.com/pt/pt-core/template-journal/lwwgateway/media/landingpage.htm?issn=0898-4921&volum26 KB (3,444 words) - 22:15, 21 September 2010
- ...It has also been shown that Alfaxalone binds to a different region of this receptor than the benzodiazipines (2). Alfaxalone is metabolised rapidly in the live ...RL, et al. A single amino acid of the human gamma-aminobutyric acid type A receptor gamma 2 subunit determines benzodiazepine efficacy. J Biol Chem 1994;269:323 KB (405 words) - 21:00, 24 September 2010
- ...n]] [[protein dimer|dimer]] complex. The [[gene]] [[encoding]] an ethylene receptor has been cloned in ''[[Arabidopsis thaliana]]'' and then in [[tomato]]. Eth Ethylene hormone receptor action in Arabidopsis. Chang C, Stadler R. Bioessays. 2001 Jul;23(7):619-2732 KB (4,462 words) - 21:01, 24 September 2010
- Etomidate is an agonist at [[GABAA receptor|GABA<sub>A</sub>]] [[Receptor (biochemistry)|receptors]]<ref>Vanlersberghe C, Camu F. Etomidate and other [[pt:Etomidato]]10 KB (1,350 words) - 21:01, 24 September 2010
- ...Receptor antagonist|antagonist]] of N-methyl-d-aspartate receptors ([[NMDA receptor]]s). These receptors exacerbate the damage from [[oxygen deprivation]] and [[Category:NMDA receptor antagonists]]82 KB (11,842 words) - 21:02, 24 September 2010
- ...l analogues: mapping binding sites for an anesthetic phenol on the GABA(A) receptor. ''Journal of Medicinal Chemistry''. 2002 Jul 18;45(15):3210–21. PMID 121 [[pt:Propofol]]21 KB (2,875 words) - 21:03, 24 September 2010
- ...0s by Dr. [[Henri Laborit]] to use in studying the neurotransmitter [[GABA receptor|GABA]].<ref>{{cite journal | author = H. Laborit, J.M. Jouany, J. Gerald, F ...}</ref> and it is a weak agonist at the [[GABA receptor|GABA<sub>B</sub>]] receptor, which is [[inhibitory]].<ref name="mechanism" /> GHB is a naturally-occurr55 KB (7,839 words) - 21:04, 24 September 2010
- [[ca:Receptor superheterodí]] [[es:Receptor superheterodino]]31 KB (4,651 words) - 14:50, 10 December 2011